Ligan, Baby Boy .

HRN: 24-32-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/29/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/29/2024
03/06/2024
IVT
30mg
Q24
Prophylaxis; Sepsis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: